Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04736173 |
|---|---|
| Brief Title: | Study Comparing the Combination Domvanalimab and Zimberelimab With Pembrolizumab in Untreated Locally Advanced or Metastatic PD-L1-High Non-Small Cell Lung Cancer (ARC-10) |
| First Submitted : | January 29, 2021 |
| First Submitted that Met QC Criteria : | January 29, 2021 |
| First Posted : | February 3, 2021 |
| Last Update Submitted that Met QC Criteria : | March 13, 2024 |
| Last Update Posted : | March 15, 2024 |